©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 112334
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.112334
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.112334
Table 5 Comparison of treatment measures between two groups, n (%)
| Indicators | Intolerance group (n = 76) | Tolerance group (n = 119) | Test statistic | P value |
| Respiratory support | ||||
| Mechanical ventilation | 68 (89.5) | 88 (73.9) | 6.298 | 0.012 |
| PEEP (cmH2O), mean ± SD | 8.4 ± 2.6 | 7.2 ± 2.1 | 3.468 | 0.001 |
| FiO2 (%), mean ± SD | 52.4 ± 18.2 | 42.8 ± 14.6 | 4.227 | < 0.001 |
| Circulatory support | ||||
| Vasoactive drug use | 60 (78.9) | 70 (58.8) | 7.941 | 0.005 |
| Vasoactive drug duration (day), mean ± SD | 8.6 ± 4.2 | 5.9 ± 3.1 | 4.873 | < 0.001 |
| Gastrointestinal therapy | ||||
| Gastrointestinal motility drug use | 68 (89.5) | 70 (58.8) | 19.586 | < 0.001 |
| Other therapies | ||||
| Antibiotic therapy duration (day), mean ± SD | 14.8 ± 6.2 | 11.2 ± 4.8 | 4.284 | < 0.001 |
| Continuous renal replacement therapy | 32 (42.1) | 31 (26.1) | 5.259 | 0.022 |
| Surgical intervention | 28 (36.8) | 31 (26.1) | 2.472 | 0.116 |
- Citation: Wu CM, Zhu WJ, Chen X, Liu M, Feng Y, Wang M. Risk factors for enteral nutrition intolerance and its impact on prognosis in patients with severe acute pancreatitis. World J Gastrointest Surg 2026; 18(1): 112334
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/112334.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.112334